Pharmaceutical company Johnson & Johnson on Thursday sought approval for the emergency use of the Corona vaccine in the US. The company has described the single dose vaccine as 66 percent effective. This will be the third vaccine to be approved in the US after approval from the Food and Drug Administration.
Washington: Pharmaceutical company Johnson & Johnson on Thursday sought approval from the US regulators for emergency use of the Corona vaccine. The company’s single dose vaccine has been described as effective against corona in global trials.
“This is an important step toward reducing the burden of disease on people globally and ending the pandemic”, said Paul Stoffels, Johnson & Johnson’s chief cytographic officer, if the vaccine was approved by the Food and Drug Administration (FDA ) Is the third vaccine to be approved in the US. Pfizer and Moderna’s vaccine has already been approved for emergency use. The need to accelerate vaccination is being felt due to the spread of variants of the virus.
The company said 66 percent effective
FDA officials said that the outside experts will discuss this on 26 February. The company had announced last week that this vaccine was 66 percent effective in global trials. It gave better protection against serious cases which was 85 percent effective. There was no hospitalization or death among the people who received the vaccine. The trial was also done in South Africa, where there was a change in the variant of Warrus.
The data has not been peer-reviewed or published, but the FDA will carefully review it to an external panel of scientists and experts. Safety and efficacy will be tested for emergency use.
Nidhi Malviya is fun loving girl. She writes at NoobFeeds about various topics related to Finance, Technology, Business etc.